한글목차

세계 동물의약품 화합물 시장은 2025년 22억 9,000만 달러, 2032년에는 42억 2,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 9.1%의 성장률을 나타낼 것으로 예상됩니다.

그림. 2025년 지역별 동물의약품 화합물 시장 점유율(%)

동물의약품은 개별 동물 환자의 필요에 따라 맞춤형으로 약물을 조제할 수 있게 함으로써 동물의료에서 중요한 역할을 하고 있습니다. 이들은 FDA가 승인한 의약품이 환자에게 필요한 적절한 강도와 용량으로 존재하지 않을 때 가장 일반적으로 사용됩니다. 배합제를 통해 수의사는 반려동물의 체격, 나이, 병력 등의 요인에 따라 맞춤형 약물과 용량을 만들 수 있습니다. 이러한 약수처리에 대한 유연한 접근 방식은 많은 동물의 치료 결과를 개선하는 데 도움이 됩니다.

시장 역학

세계 동물의약품 화합물 시장의 성장은 지난 몇 년동안 반려동물 양육률 증가와 반려동물 관리에 대한 지출 증가 등의 요인에 의해 주도되고 있습니다. 반려동물 보호자들 사이에서 반려동물에게 맞춤형 의료 서비스를 제공하고자 하는 인식이 높아지면서 시장 성장의 원동력이 되고 있습니다. 그러나 배합 의약품에 대한 규제와 품질 기준의 부재는 안전 위험을 초래하고 시장 성장을 저해할 수 있습니다. 제형의 용량 및 제형의 유연성과 같은 장점은 시장 기업에게 유리한 기회를 제공합니다. 이러한 시설에 대한 품질 모니터링을 강화하기 위한 최근 FDA 지침은 시장 성장을 가속할 수 있습니다.

본 조사의 주요 특징

• 세계의 동물의약품 화합물 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안 시장 규모(10억 달러)와 연평균 복합 성장률(CAGR)을 예측한 보고서입니다.
• 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 동물의약품 화합물 시장의 주요 기업을 프로파일링합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 동물의약품 화합물 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 동물의약품 화합물 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 동물의약품 화합물 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 동물의약품 화합물 시장, 약제 클래스별, 2020년-2032년(10억 달러)

• CNS 에이전트
• 항감염제
• 호르몬 및 대체품
• 항염증제
• 기타

제6장 세계의 동물의약품 화합물 시장, 동물 유형별, 2020년-2032년(10억 달러)

• 반려동물
• 개
• 고양이
• 기타
• 가축

제7장 세계의 동물의약품 화합물 시장, 처방별, 2020년-2032년(10억 달러)

• 경구
• 주사
• 기타

제8장 세계의 동물의약품 화합물 시장, 지역별, 2020년-2032년(10억 달러)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 개요
  • Wedgewood Pharmacy
  • Diamondback Drugs LL
  • Stokes Pharmacy
  • MEDISCA
  • Patterson Companies, Inc.
  • Boehringer Ingelheim
  • Zoetis Inc.
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck &Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol SA
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

제10장 애널리스트 추천 사항

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제11장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Veterinary Drugs Compounding Market is estimated to be valued at USD 2.29 Bn in 2025 and is expected to reach USD 4.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Figure. Veterinary Drugs Compounding Market Share (%), By Region 2025

Compounded medications play an important role in veterinary medicine by allowing for customized medication preparations tailored to individual animal patients' needs. These are most commonly used when an FDA-approved drug may not exist in the appropriate strength or dosage form required for a patient. Compounded drugs allow veterinarians to create customized medications and doses depending on factors like pet's size, age, or medical condition. This flexible approach to medication can help improve treatment outcomes for many animals.

Market Dynamics:

Global veterinary drugs compounding market growth is driven by factors such as rising pet ownership and increased spending on pet care over the past few years. Growing awareness among pet owners about providing customized medical care to their animals can drive the market growth. However, lack of regulation and quality standards for compounded drugs poses safety risks and can hamper the market growth. Advantages like flexibility in dosages and forms for compounded drugs present lucrative opportunities for market players. Recent FDA guidelines to strengthen quality oversight of these facilities could drive the market growth.

Key features of the study:

• This report provides in-depth analysis of the global veterinary drugs compounding market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary drugs compounding market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Patterson Veterinary, Chase Pharmaceuticals, Kentucky Performance Products, Animal Medics and Rx3 Compounding
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global veterinary drugs compounding market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary drugs compounding market.

Detailed Segmentation-

• By Drug Class
  • CNS Agents
  • Anti-infective Agents
  • Hormones and Substitutes
  • Anti-inflammatory Agents
  • Others
• By Animal Type
  • Companion Animals
  • Dogs
  • Cat
  • Others
  • Livestock Animals
• By Formulation
  • Oral
  • Injectable
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Wedgewood Pharmacy
  • Diamondback Drugs LL
  • Stokes Pharmacy
  • MEDISCA
  • Patterson Companies, Inc.
  • Boehringer Ingelheim
  • Zoetis Inc.
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Formulation
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Veterinary Drugs Compounding Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Veterinary Drugs Compounding Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• CNS Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-infective Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hormones and Substitutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Anti-inflammatory Agents
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Veterinary Drugs Compounding Market, By Animal Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Companion Animals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dogs
• Cat
• Others
• Livestock Animals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Veterinary Drugs Compounding Market, By Formulation, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injectable
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Veterinary Drugs Compounding Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Wedgewood Pharmacy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Diamondback Drugs LL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stokes Pharmacy
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • MEDISCA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Patterson Companies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boehringer Ingelheim
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Covetrus
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Elanco
  • Kindred Biosciences, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Putney, Inc.
  • Norbrook Laboratories Limited
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Rood and Riddle Veterinary Pharmacy
  • Mwi Veterinary Supply Co.

10. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact